Search

Your search keyword '"Cohen E"' showing total 309 results

Search Constraints

Start Over You searched for: Author "Cohen E" Remove constraint Author: "Cohen E" Publisher elsevier bv Remove constraint Publisher: elsevier bv
309 results on '"Cohen E"'

Search Results

2. Lenvatinib ± Pembrolizumab Versus Chemotherapy for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Progressed after Platinum and Immunotherapy: The Phase 2 LEAP-009 Study

5. Sarcoïdoses cutanées hypodermiques : étude française multicentrique de 80 patients

7. ALLEVIATION OF CARBOHYDRATE COUNTING IN TYPE 1 DIABETES WITH AUTOMATED FASTER ASPART AND PRAMLINTIDE CLOSED-LOOP DELIVERY (ARTIFICIAL PANCREAS): A RANDOMIZED CONTROLLED TRIAL

8. 1038P A phase II trial of the IO102-IO103 vaccine plus pembrolizumab: preliminary analysis for first-line (1L) treatment of non-small cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN)

9. Design and simulated performance of calorimetry systems for the ECCE detector at the electron ion collider

11. ECCE unpolarized TMD measurements

12. Search for e→τ charged lepton flavor violation at the EIC with the ECCE detector

13. Detector requirements and simulation results for the EIC exclusive, diffractive and tagging physics program using the ECCE detector concept

16. ECCE sensitivity studies for single hadron transverse single spin asymmetry measurements

20. Exclusive J/ψ detection and physics with ECCE

22. Scientific computing plan for the ECCE detector at the Electron Ion Collider

23. AI-assisted optimization of the ECCE tracking system at the Electron Ion Collider

25. 46P Development of an allogeneic CAR-T targeting MUC1-C (MUC1, cell surface associated, C-terminal) for epithelial derived tumors

26. Sarcoïdose cutanée, quelle première ligne de traitement ? Étude rétrospective de 120 cas

27. EP08.01-044 A Phase 2 Multi-Cohort Study of Tiragolumab, Atezolizumab and Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Cancer

30. Phase 2 LEAP-009: Lenvatinib (Lenva) With or Without Pembrolizumab (Pembro) vs. Chemotherapy (Chemo) for Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That has Progressed on Platinum and Immunotherapy

34. Complex chronic conditions among children born to women with schizophrenia

36. DISTAL MYOPATHIES

37. NEW GENES AND DISEASES

38. 927TiP SKYSCRAPER-09: A phase II, randomised, double-blinded study of atezolizumab (Atezo) + tiragolumab (Tira) and atezo + placebo as first-line (1L) therapy for recurrent/metastatic (R/M) PD-L1+ squamous cell carcinoma of the head and neck (SCCHN)

41. 71P A phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: Preliminary safety, efficacy and PK/PD results

45. OMICs AND AI APPROACHES FOR MUSCLE DISEASES

46. The CLAS12 Backward Angle Neutron Detector (BAND)

48. Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages

49. An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): updated results of cohort 1 analysis

Catalog

Books, media, physical & digital resources